Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Goldman Sachs

College students are voting with their feet on AI. Goldman has the receipts

If you were a student right now, what major would you choose?

Fortune

Goldman’s S&P 500 Target Looks More Reachable After the Latest Rally

Goldman Sachs raised its S&P 500 year-end target to 8,000, citing EPS growth, broad earnings beats, and IPO activity including SpaceX's June 12 debut at $135 per share.

MarketBeat

Chinese social media firm Xiaohongshu taps Goldman, CICC to work on Hong Kong IPO

Chinese social media platform Xiaohongshu is preparing for a potential Hong Kong initial public offering. Banks including Goldman Sachs and CICC are reportedly working on the deal. The company, also known as RedNote, could list as early as the second half of this year. This move follows a previous attempt…

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Nvidia to raise $25 billion in first corporate bond sale in five years

Nvidia is set to raise a massive $20 billion through a bond issuance. This move signals the company's significant investment in artificial intelligence infrastructure. Big technology firms are increasingly turning to debt markets to finance their ambitious AI projects. This bond issuance, with maturities extending to 2056, highlights the substantial…

The Economic Times

A $1.24 Trillion Reason to Buy Dell Stock Now

Dell is riding powerful AI and server tailwinds, steadily expanding market share while growth forecasts keep moving higher.

Barchart

How Musk's tactics left investors clamoring for SpaceX stock and ignoring risks

One investor said that when SpaceX was privately held, he used a connection with a cousin of the billionaire entrepreneur to buy $10 million worth of stock in the satellite maker in 2018. A portfolio manager at a $500 billion U.S. fund said he had to use his relationship with…

The Economic Times

The economist who said ‘no bubble’ just sounded the alarm: ‘The season of chaos is at hand’

“The chamber of dispersion has been opened,” Owen Lamont says. “The beast of volatility has awakened, and the season of chaos is at hand.”

Fortune

Read news from The Economist, FT, and more,
with one subscription

Lenskart block deal; Meesho's kirana push

Lenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.

The Economic Times

Lenskart shares in focus as Goldman Sachs, Morgan Stanley, others purchase stake in Rs 1,960 crore block deal

Lenskart Solutions saw significant stake activity as marquee investors bought Rs 1,960 crore in a block deal, with Platinum Jasmine A 2018 Trust paring its holding. Despite recent exits, brokerages remain optimistic about Lenskart's long-term growth, citing its integrated model and international expansion.

The Economic Times

SpaceX lowballed its bankers on fees. Goldman Sachs has another way to win big

The real money comes after the opening bell.

Fortune

After record IPO, SpaceX faces test in market debut

SpaceX has made history after raising $106 billion to become the biggest IPO ever. Now the market is set to find out the strength of the stock's "Musk premium".

AAP

US stocks: Musk's SpaceX prices record $75 billion IPO at $135 a share

SpaceX has priced its record-breaking U.S. IPO at $135 per share, raising $75 billion and valuing the company at $1.77 trillion. This makes it one of the world's most valuable companies, surpassing established giants. The offering, which saw significant retail allocation, culminates Elon Musk's ambitious project despite questions about its…

The Economic Times

Honasa shares jump 6% on Rs 5,500 crore revenue target by FY31. What is Goldman Sachs saying?

Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth rate of around 18% between FY26 and FY31. Growth is expected to be led by Mamaearth, with revenue projected to exceed ₹2,000 crore, while The Derma Co is…

The Economic Times

Grain Market Update: Are Corn, Wheat, and Soybeans Finally Carving Out a Summer Bottom?

Barchart Senior Market Analyst Darin Newsom analyzes whether the morning's short-covering bounce in grains is a temporary reprieve or a permanent bottom, while breaking down the technical realities of the Goldman roll, a hot 4.2% CPI print, and the critical cash-market triggers dictating the cattle pits.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Billionaire Sam Altman Says OpenAI Was ‘Pretty Wrong’ About AI Jobs, But Goldman Sachs Warns AI is Still Wiping Out 11,000 Jobs Per Month

The AI jobs story has become a split screen: one of the most powerful artificial intelligence (AI) executives is walking back the worst panic, while data tracked by Goldman Sachs (GS ) still points to pressure on younger white-collar workers. The lack of a clean yes-or-no answer is exactly why...

The Economic Times

Goldman Sachs buys CMR Green Technologies shares on listing day after strong debut

Goldman Sachs India Equity Portfolio bought shares worth Rs 49.82 crore in CMR Green Technologies on its listing day, which saw a 43% premium. Despite investor optimism, analysts advise caution and partial profit booking amid high valuations.

Fortune

‘The circulatory system is not working.’ Goldman on what’s really wrong with private markets

Goldman Sachs’ top private markets executives say the industry has reached a structural inflection point—not a crisis. Not everyone agrees.

Fortune

A $7 billion horse race: Goldman Sachs and Morgan Stanley battle to lead OpenAI and Anthropic IPOs

Only one bank can occupy the coveted lead underwriter position for this year's hottest AI IPOs.

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times

SpaceX aims to launch orbital AI computing tests by end of next year

During two investor presentations ahead of the IPO, both featuring President Gwynne Shotwell and Chief Financial Officer Bret Johnsen, SpaceX executives outlined a roadmap to begin demonstrating orbital-compute capabilities in 2027, according to the two people familiar with the discussions. Both sources were at a Goldman Sachs meeting and one…

MarketBeat

Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase

Amneal Pharmaceuticals (NASDAQ:AMRX) Co-Founder, President and Co-Chief Executive Officer Chirag Patel said the company is entering a stronger growth phase, driven by momentum in its existing generics portfolio, a newly expanded biosimilars platform and specialty product launches. Speaking at a Gol

MarketBeat

Alnylam Pharmaceuticals Unveils 2030 Targets, Betting on AMVUTTRA and Pipeline Readouts

Alnylam Pharmaceuticals (NASDAQ:ALNY) executives outlined the company’s 2030 financial targets, TTR franchise strategy and near-term pipeline priorities during a Goldman Sachs event hosted by analyst Salveen Richter. Jeff Poulton, Alnylam’s chief financial officer, said the company’s “Alnylam 2030”

MarketBeat

Amgen Eyes 2026 ‘Springboard’ as Growth Drugs Offset Patent Pressure

Amgen (NASDAQ:AMGN) executives said the company’s first-quarter performance supports its view that 2026 can serve as a “springboard year,” with growth products helping offset increased competition for the denosumab franchise and other losses of exclusivity. Speaking at a Goldman Sachs event, Peter

The Economic Times

IndiGo shares gain 2% after analyst meet. Why Goldman, Morgan Stanley, others see up to 38% upside?

IndiGo shares witnessed an uptick on Tuesday after its analyst meet, where management outlined strong long-term growth plans driven by rising air travel demand and international expansion. Brokerages including Goldman Sachs, Morgan Stanley, Motilal Oswal and Elara Capital reiterated bullish views, seeing up to 38% upside despite near-term geopolitical and…

The Economic Times

Gold extends falls on rising Treasury yields

Gold prices dipped for a third consecutive session, influenced by rising Treasury yields and ongoing Middle East conflict concerns. Goldman Sachs anticipates the Fed will hold rates steady through 2026, while Citi lowered its near-term gold price target due to expected higher U.S. interest rates.

MarketBeat

CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans

CareDx (NASDAQ:CDNA) executives outlined the company’s strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted discussion. Chief Executive Officer John Hanna said CareDx has reshaped its portfolio around areas

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.